Prevention of graft-versus-host disease (GVHD) by elimination of recipient-reactive donor T cells with recombinant toxins that target the interleukin 2 (IL-2) receptor
- 1 January 1999
- journal article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 23 (2), 137-144
- https://doi.org/10.1038/sj.bmt.1701535